Stanford Cancer Institute & Collaborations #16ICML #002: Architecture of #lymphoma #liquidbiopsy #006: #AxiCel #CART19 #ctDNA (plenary) #023: CHIP & cfDNA in DLBCL #025: PhasED-Seq #MRD in DLBCL #046: PhasED-Seq #PCNSL w Florian Scherer MD #139: CIRI2 for CLL w #GCLLSG Othman Al-Sawaf

.Stanford Medicine, HHMI scientists have developed a new #technology that detects a wider variety of cross-reactive T cells that recognize coronaviruses, including #SARSCoV2. The spheromer, pictured here, improves upon previous #Tcell detection methods: fcld.ly/m21b4iy

[Please RT] We are hiring a research assistant in the Chang lab Stanford Medicine! This person will work with me on exciting research aiming to understand how oncogenes on extrachromosomal DNA drive cancer. Apply here: m.rfer.us/STANFORDS85G8B

Our paper is out in nature! Extrachromosomal DNA molecules huddle together in cancer cells to activate oncogene expression (which we call ecDNA hubs). A great collaboration with Katie Yost, Howard Chang, Frank Xie lab, Zhe Liu, and others. (1/10) nature.com/articles/s4158…

Very happy to see our study in print Nature Immunology today! BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2. rdcu.be/cCkOj

We are hiring HHMI | Janelia! systems cell surface biology, neuro, immune, method development... lilab.science/join-us

Very excited to share our new study on determinants of resistance to anti-CD19 CAR T-cells (CART19) in large B-cell lymphomas (LBCLs)! Out today in Cancer Cell /1 cell.com/cancer-cell/fu…

Great experience collaborating with an amazing bioengineer @QianY20878657. Putting a TLR7 agonist in special nanoparticles can change the quality of GC response, leading to the generation of antibodies targeting subdominant epitopes (e.g stem of HA). nature.com/articles/s4156…

Excited to share our work on antigen-specific #tcell responses post #mRNA #COVID19 #vaccine using the new #spheromer technology! Out now in Immunity Jodi Gullicksrud cell.com/immunity/fullt… (1/n)

Excited to share my PhD work, out today in Cell! Thankful for a great team and my mentor Irv Weissman. A rundown of the study: "Purification and characterization of human neural stem and progenitor cells." 1/ cell.com/cell/fulltext/…

A significant advance in solving the TCR-antigen prediction problem that demonstrates the power of improving data quality/quantity and models in parallel. The generative model in Fig. 7 is a peek into the future of this field. Incredible work by Binbin, Ethan, and Manjima!

I'm seeking a computational postdoc for my team Stanford Radiation Oncology! We're building ML tools to crack genomic data for enhancing early cancer detection (and more). Join us!🧬💻 Please RT! postdocs.stanford.edu/prospective/op…

Kazuki is an excellent scientist and a kind person. He has a new perspective on how to study the intersection of our microbiome & immunity. This is a great (and early) opportunity to join a lab that’s sure to enrich our understanding of this important field in the coming years.

Beautiful work from Djenet Bousbaine and Michael Fischbach characterizing the immune response to a human skin commensal and its utility as a vaccination platform. Remarkable antibody response kinetics worthy of an entirely new study.

Please have a look to our new publication in Immunity. cell.com/immunity/fullt… (Immunity )!

Our new study, “Modeling glioma intratumoral heterogeneity with primary human neural stem and progenitor cells,” is online now at StemCellReports! Spearheaded by our talented undergrad Daniel. A thread on the study: 1/ cell.com/stem-cell-repo…